Zygophyllum fabago is a herbaceous plant found widely in the Mediterra
nean area. There are no previous reports of its allergenicity. An aero
biologic and clinical survey was conducted in Murcia, southern Spain,
to determine the quantity of airborne pollen and establish the possibl
e role of this pollen as a cause of allergic symptoms. With a Hirst vo
lumetric trap, we determined the atmospheric concentrations of this po
llen in 1993, 1994, 1995, and 1996. Of 1180 patients tested, 181 (15.3
4%) had a positive skin test. To determine its allergenicity, we divid
ed 47 patients into three groups: in group 1, all the patients had sym
ptoms of rhinoconjunctivitis plus asthma; in groups 2 and 3, rhinoconj
unctivitis. In group 1, we performed a bronchial provocation test (BPT
); in groups 2 and 3, we performed nasal provocation (NPT) and conjunc
tival provocation (CPT) tests, respectively. SDS-PAGE was used to char
acterize the antigenic fractions and RAST inhibition to determine cros
s-reactivity with other pollens. The pollen dispersion period is from
May to September (445 grains/m(3)). BPT was positive in 13 of 15 patie
nts, NPT in 14 of 16 patients, and CPT in 13 of 16 patients. RAST inhi
bition revealed cross-reactivity with Mercurialis, Ricinus, Olea, and
Betula. SDS-PAGE identified 25 IgE antibody-binding components, five o
f which (60, 65, 41, 38, and 15.5/14.7 kDa) were recognized by 40% of
the sera. By SDS-PAGE immunoblotting with sunflower antiprofilin rabbi
t serum and affinity chromatography we established that the Z. fabago
extract has profilin. This study shows that this pollen becomes airbor
ne and elicits an IgE response which triggers respiratory symptoms in
allergic subjects.